Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form publ ...
FOMAT is committed to providing high-quality services. We also aim to bring diversity and innovative healthcare to underrepresented populations in our community. That is why we present to you our company’s new ambulance! With our ambulance, we plan o ...
Why volunteer in clinical trials? Here's a summary of the reasons why clinical trials are important Clinical trials are research studies that use human participants to help evaluate new medical treatments, drugs, or devices. They are an essential to ...
The Oxnard Chamber of Commerce has awarded FOMAT as the Innovative Company of the Year. Oxnard, California, October 5th, 2020FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10 ...
The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Bi ...
Febo is a digital upstart, with its sights set on empowering patients by transforming the way they educate themselves. Febo is an online platform where you can get personalized information about your medical interests and stay updated on the newest d ...
Last weekend several prominent members of the clinical research industry gathered at the 2019 Global Site Solutions Summit hosted at the Diplomat Beach Resort in Hollywood Florida. This marks the 14th year in a row that the event has been held, and i ...
Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeut ...
Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the main goals for a CRO is to create a mitigating strategy that overcomes t ...
hyperCORE International took first place in the inaugural ACRP All-Star Challenge for Sites during the ACRP 2019 annual conference in Nashville. Vanderbilt University Medical Center took second place, and Sarah Cannon Research Institute placed thi ...